ArticleSurgical case reports2025
Collision Tumor of Gallbladder Carcinosarcoma and Intrahepatic Cholangiocarcinoma: A Rare Case Report.
Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MRI findings of intrahepatic cholangiocarcinoma with sarcomatoid differentiation: a retrospective case series.BMC medical imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGallbladder carcinosarcoma is extremely rare, with fewer than 100 cases reported from its first description in 1907 until 2022. Collision carcinoma is a type of synchronous carcinoma in which 2 independently arising tumors come into contact or partially invade each other. CASE PRESENTATION: A man in his 80s was referred to our hospital with the primary complaints of weight loss and decreased appetite. Contrast-enhanced computed tomography revealed a large lobular tumor with heterogeneous enhancement, measuring 66 mm in maximum diameter, located in the fundus of the gallbladder. The mass showed clear signs of liver invasion, raising immediate concerns of malignancy. Magnetic resonance imaging provided additional crucial details. The lesion exhibited low signal intensity on T1-weighted images and high signal intensity on T2-weighted images. Notably, diffusion-weighted imaging demonstrated restricted diffusion, a characteristic often associated with malignant processes. These findings strongly suggested gallbladder cancer with liver invasion. The patient underwent cholecystectomy and hepatectomy involving segments 4, 5, and 8 of the liver. A subsequent pathological examination revealed a complex and unusual tumor composition. The hepatic lesion showed nests of varying sizes with a medullary growth pattern, which is characteristic of intrahepatic cholangiocarcinoma. In contrast, the gallbladder lesion displayed features of adenosquamous carcinoma with a partial sarcomatoid morphology, indicative of gallbladder carcinosarcoma. Intriguingly, the interface between these 2 distinct tumor types exhibited unique characteristics. In some areas, normal hepatocytes were interspersed between the 2 types of tumor cells. Other regions demonstrated an invasive tendency of tumor cells towards each other. This unusual pattern led to the diagnosis of a collision tumor, a rare occurrence in which 2 independent primary malignancies coexist in the same organ or site.
conclusionsThis was an extremely rare case of collision carcinoma involving both intrahepatic cholangiocarcinoma and gallbladder carcinosarcoma. The unique pathological findings and rarity of this tumor combination make this case particularly noteworthy. We present this case to contribute to the limited literature on such rare tumors, aiming to facilitate a better understanding and management of similar cases in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.